Novel models to personalise cancer therapeutics
4 Jul 2017
Novel models to personalise cancer therapeutics
Benefits of skin and nipple saving mastectomy
Low dose exemestane usage in breast cancer
BRCA1 and BRCA2 genes and hereditary breast cancers
Stage 4 breast cancer surgery
The Umberto Veronesi Milan Breast Cancer Conference
4 years of RESONATE data for CLL patients treated with ibrutinib
Hemcare - multiple myeloma learning programme
Enasidenib in mIDH relapsed and refractory AML
Impact of mutational profile at diagnosis for MDS/CML
Delayed infection exposure as a trigger for childhood ALL
The role of patient advocates in trial design, participation